Market Cap 257.56M
Revenue (ttm) 1.04B
Net Income (ttm) -190.60M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 4.07
Profit Margin -18.26%
Debt to Equity Ratio 1.37
Volume 1,928,478
Avg Vol 1,265,258
Day's Range N/A - N/A
Shares Out 54.34M
Stochastic %K 46%
Beta 2.14
Analysts Sell
Price Target $14.33

Latest News on EBS

Emergent BioSolutions Announces Stock Repurchase Program

Mar 31, 2025, 8:00 AM EDT - 2 days ago

Emergent BioSolutions Announces Stock Repurchase Program


Emergent BioSolutions: Stock Is A Likely Winner In 2025

Jan 14, 2025, 7:53 AM EST - 2 months ago

Emergent BioSolutions: Stock Is A Likely Winner In 2025


Emergent BioSolutions Stock Soars as FDA Approves Mpox Vaccine

Aug 30, 2024, 7:15 AM EDT - 7 months ago

Emergent BioSolutions Stock Soars as FDA Approves Mpox Vaccine


Health stocks jump as WHO declares mpox global health emergency

Aug 15, 2024, 11:26 AM EDT - 8 months ago

Health stocks jump as WHO declares mpox global health emergency